Latest News

UCI Alpha Stem Cell Clinic - Clinical Research Coordinator Training Program (CRCTP)

UCI

June 22, 2022

CIRM Board Approves Funding for Clinical Trials Targeting Epilepsy and Dysphagia | California's Stem Cell Agency

CIRM

May 26, 2022

Businesses selling non-FDA-approved stem cell products grew four-fold in five years, UCI study says

UCI News

November 4, 2021

Natural killer cells show potential to treat COVID-19 symptoms

UCI Health

August 13, 2021

FDA Approves StrataGraft for the Treatment of Adults with Thermal Burns

CIRM Blog

June 15, 2021

CIRM Funded Trial for Parkinson’s Treats First Patient

CIRM Blog

September 14, 2020

Diomics Corporation and University of California, Irvine Collaborate to Enable Cell Therapy Clinical Trial for Type 1 Diabetes

GlobalNewsWire

September 4, 2020

CIRM Award for COVID-19 Treatment

ASCC

August 5, 2020

Working with the City of Hope in clinical study for potential treatment for COVID-19

ASCC

July 24, 2020

A phase I/II study of human placental hematopoietic stem cell derived natural killer cells (CYNK-001) for the treatment of adults with COVID-19

CIRM Press Release

July 23, 2020

Potential Risks of Treatment with Unapproved Regenerative Medicine Products

FDA

July 22, 2020

Identifying the Risks of Unproven Regenerative Medicine Therapies

JAMA Network

June 17, 2020

CIRM Board Expands COVID-19 Efforts

CIRM Blog

April 10, 2020

Clinical trials: separating the wheat from the chaff

CIRM Blog

June 14, 2019